Use of inhaled corticosteroids in asthma and coronavirus disease 2019
Inhaled corticosteroids (ICS) are used as anti-inflammatory controller therapy given either alone or in a combination with long-acting bronchodilators for persistent asthma. The novel coronavirus disease 2019 (COVID-19) pandemic has inevitably focused attention on whether ICS could predispose to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, especially in older, male, obese, smokers with comorbidities including chronic lung diseases who are susceptible to severe COVID-19 infection and worse outcomes.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Brian Lipworth, Rory Chan, Chris RuiWen Kuo Tags: Perspective Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Coronavirus | Corticosteroid Therapy | COVID-19 | Eating Disorders & Weight Management | Obesity | Pandemics | Respiratory Medicine | SARS | Smokers